The Bio-manufacturing Congress brings you the latest Innovation, current trends, strategic insights and technology in Biologicals, Cell & Gene Therapy.  The Lastest Key Themes include:

Fundamental evolution to meet Quality and Process Challenges Enabling acceleration of processing research and scale-up considerations:  Implementation of AI, digital bioprocessing 4.0, integrating automation to increase manufacturing efficiency, increased GMP compliance and consistency.

Achieving continuous bioprocess and product improvement whilst maintaining comparability:  Process and product improvement cost reduction strategies throughout manufacturing operations.

Next-generation Gene Therapy Innovation:  AAV Manufacturing and Viral Vector Technologies ensuring quality and consistency in production.  Staying ahead of the curve in compliances whilst navigating the shifting regulatory terrain.

Process Development and Manufacturing:  Advances in Innovation shaping the Future of Cell & Gene Therapy development.

The Future of Upstream Automation:  AI-powered continuous processing platforms reduces optimization timelines and volumetric productivity challenges

Leveraging Innovation & next generation technology to transform biological manufacturing productivity & processes:  An integrated approach to stream-line and deliver a fully functional, cost effective production process across the entire production line.

Cell Line Engineering:  Automated CHO Cell lines and Expression System for enhanced improved productivity.  Accelerate Timelines by Integrating Cell Line Development and Manufacturing Programs.

Tackling Downstream Bottlenecks from High-Titer Upstream:  Optimizing purification processes to manage high upstream titers and process adjustments to maintain product quality. 

Optimization of fermentation/cell culture media:  Explore next generation Technology, strategies and Innovation that Improves Cell Culture Process Development to increase yield, reduce wastage and consistently produce high quality biological end product.

Embracing digital transformation and pioneering high-tech new strategies across the supply chain:  Optimizing the supply chain end-to-end to meet the needs of patients and anticipate how to meet their needs tomorrow in a transformational way.  Seeing digital and Industry 4.0 technologies as the next driver of innovation and patient-centricity.

Ensuring quality management in collaborations and outsourcing:  New approaches to Contract/Outsourcing relationships, project management and methods/technology transfer, reducing delays by setting up clear quality management processes and decision-making plans with CDMO's.

High throughput analytics & process development:  Techniques to accelerate processing research and scale-up considerations. Implementation of an Adventitious Detection Assay Using High Throughput. Combining data and connecting all process steps together.

​